Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 610

Results For "Act"

7963 News Found

A.Menarini expands its dermatology portfolio with the launch of Solar D
Healthcare | May 27, 2022

A.Menarini expands its dermatology portfolio with the launch of Solar D

The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D


Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities
News | May 26, 2022

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities

ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E


Honeywell and Narayana Health partner to explore co-creation of healthcare technologies
Digitisation | May 26, 2022

Honeywell and Narayana Health partner to explore co-creation of healthcare technologies

Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies


Lumenis OptiLight wins 2022 MedTech Breakthrough Award
News | May 26, 2022

Lumenis OptiLight wins 2022 MedTech Breakthrough Award

For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies


ASG Eye Hospitals opens unit in Dombivli, Maharashtra
Hospitals | May 26, 2022

ASG Eye Hospitals opens unit in Dombivli, Maharashtra

The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra


Eugia Pharma receives USFDA approval for Pemetrexed
Drug Approval | May 26, 2022

Eugia Pharma receives USFDA approval for Pemetrexed

Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)


Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection
Drug Approval | May 26, 2022

Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection

Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)


Lonza partners with Israel Biotech Fund to support biologics and small molecules development
Biotech | May 25, 2022

Lonza partners with Israel Biotech Fund to support biologics and small molecules development

The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets


Sputnik V demonstrates strong protection against Omicron variant
Biotech | May 25, 2022

Sputnik V demonstrates strong protection against Omicron variant

The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.


Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022
Sustainability | May 25, 2022

Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022

By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry